Current Ratio of CytomX Therapeutics, Inc. from 30 Jun 2016 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
CytomX Therapeutics, Inc. quarterly Current Ratio in % history and change rate from 30 Jun 2016 to 30 Sep 2025.
  • CytomX Therapeutics, Inc. Current Ratio for the quarter ending 30 Sep 2025 was 235%, a 114% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

CytomX Therapeutics, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 235% +125% +114% 30 Sep 2025
Q2 2025 164% +46% +39% 30 Jun 2025
Q1 2025 116% -9.7% -7.7% 31 Mar 2025
Q4 2024 110% -22% -16% 31 Dec 2024
Q3 2024 110% -32% -22% 30 Sep 2024
Q2 2024 118% -30% -20% 30 Jun 2024
Q1 2024 126% -43% -26% 31 Mar 2024
Q4 2023 132% -73% -36% 31 Dec 2023
Q3 2023 142% -122% -46% 30 Sep 2023
Q2 2023 147% -174% -54% 30 Jun 2023
Q1 2023 169% -203% -55% 31 Mar 2023
Q4 2022 205% -247% -55% 31 Dec 2022
Q3 2022 264% -210% -44% 30 Sep 2022
Q2 2022 321% -131% -29% 30 Jun 2022
Q1 2022 372% -56% -13% 31 Mar 2022
Q4 2021 452% +70% +18% 31 Dec 2021
Q3 2021 474% +114% +32% 30 Sep 2021
Q2 2021 452% +69% +18% 30 Jun 2021
Q1 2021 429% +23% +5.7% 31 Mar 2021
Q4 2020 382% -37% -8.9% 31 Dec 2020
Q3 2020 359% -85% -19% 30 Sep 2020
Q2 2020 383% -87% -19% 30 Jun 2020
Q1 2020 406% -59% -13% 31 Mar 2020
Q4 2019 419% -71% -15% 31 Dec 2019
Q3 2019 445% -86% -16% 30 Sep 2019
Q2 2019 471% -55% -10% 30 Jun 2019
Q1 2019 465% -96% -17% 31 Mar 2019
Q4 2018 490% -63% -11% 31 Dec 2018
Q3 2018 531% +7.4% +1.4% 30 Sep 2018
Q2 2018 525% -34% -6.1% 30 Jun 2018
Q1 2018 561% -61% -9.8% 31 Mar 2018
Q4 2017 553% -213% -28% 31 Dec 2017
Q3 2017 524% -439% -46% 30 Sep 2017
Q2 2017 559% -440% -44% 30 Jun 2017
Q1 2017 621% 31 Mar 2017
Q4 2016 766% 31 Dec 2016
Q3 2016 963% 30 Sep 2016
Q2 2016 999% 30 Jun 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.